284
Views
16
CrossRef citations to date
0
Altmetric
Review Articles

The Impact of Dietary Polyphenols on COX-2 Expression in Colorectal Cancer

&
Pages 1105-1118 | Received 03 Aug 2016, Accepted 21 Jul 2017, Published online: 25 Oct 2017

References

  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al.: Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108, 2015.
  • Haggar FA, and Boushey RP: Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22, 191–197, 2009.
  • Center MM, Jemal A, and Ward E: International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18, 1688–1694, 2009.
  • Santarelli RL, Pierre F, and Corpet DE: Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer 60, 131–144, 2008.
  • Afrin S, Giampieri F, Gasparrini M, Forbes-Hernandez TY, Varela-López A, et al.: Chemopreventive and therapeutic effects of Edible berries: a focus on colon cancer prevention and treatment. Molecules 21, 1–40, 2016.
  • Jaganathan SK, Vellayappan MV, Narasimhan G, Supriyanto E, Octorina Dewi DE, et al.: Chemopreventive effect of apple and berry fruits against colon cancer. World J Gastroenterol 20, 17029–17036, 2014.
  • Brown EM, Latimer C, Allsopp P, Ternan NG, McMullan G, et al.: In Vitro and in Vivo models of colorectal cancer: antigenotoxic activity of berries. J Agric Food Chem 62, 3852–3866, 2014.
  • Tang TC, Poon RT, Lau CP, Xie D and Fan ST: Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J Gastroenterol 11, 1896–1902, 2005.
  • Xu L, Stevens J, Hilton MB, Seaman S, Conrads TP, et al.: COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci Transl Med 6, 242ra84, 2014.
  • Smith WL, DeWitt DL, and Garavito RM: Cyclooxygenases: structural, cellular and molecular biology. Annu Rev Biochem 69, 145–182, 2005.
  • Claus S and Ambra P: Cyclooxygenases and lipoxygenases in cancer. Cancer Metastasis Rev 30, 277–294, 2011.
  • Cuendet M, and Pezzuto JM: The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metab Drug Interact 17, 109–157, 2000.
  • Misron NA, Looi LM, and Nik Mustapha NR: Cyclooxygenase-2 expression ininvasive breast carcinomas of no special type and correlation withpathological profiles suggest a role in tumorigenesis rather than cancerprogression. Asian Pac J Cancer Prev 16, 1553–1558, 2015.
  • Wang D and Dubois RN: Eicosanoids and cancer. Nat Rev Cancer 10, 181–193, 2010.
  • Aggarwal BB and Gehlot P: Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol 9, 351–369, 2009.
  • Itzkowitz SH and Yio X: Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287, 7–17, 2004.
  • Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, et al.: Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107, 1183–1188, 1994.
  • Krysan K, Reckamp KL, Sharma S and Dubinett SM: The potential and rationale for COX-2 inhibitors in lung cancer. Anticancer Agents Med Chem 6, 209–220, 2006.
  • Ristimäki A, Sivula A, Lundin J, Lundin M, Salminen T, et al.: Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62, 632–635, 2002.
  • Gupta RA and Dubois RN: Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1, 11–21, 2001.
  • Bozimowski G: A review of nonsteroidal anti-inflammatory drugs. AANA J 83 (6), 425–433, 2015.
  • Laine L: Upper gastrointestinal bleeding due to a peptic ulcer. N Engl J Med 374, 2367–2376, 2016.
  • Pan MH, Lai CS, Dushenkov S and Ho CT: Modulation of inflammatory genes by natural dietary bioactive compounds. J Agric Food Chem 57, 4467–4477, 2009.
  • Meyskens FL and Szabo E: Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol Biomarkers Pre V 14, 1366–1369, 2005.
  • Liu YF, Bai YQ and Qi M: Daidzein attenuates abdominal aortic aneurysm through NF-κB, p38MAPK and TGF-β1 pathways. Mol Med Rep 14, 955–962, 2016.
  • Moosavi F, Hosseini R, Saso L and Firuzi O: Modulation of neurotrophic signaling pathways by polyphenols. Drug Des Devel Ther 10, 23–42, 2015.
  • Park SY, Chae SY, Park JO, Lee KJ and Park G: Gold-conjugated resveratrol nanoparticles attenuate the invasion and MMP-9 and COX-2 expression in breast cancer cells. Oncol Rep 35, 3248–3256, 2016.
  • Singh BN, Prateeksha, Rawat AK, Bhagat RM and Singh BR: Black tea: phytochemicals, cancer chemoprevention and clinical studies. Crit Rev Food Sci Nutr 57, 1394–1410, 2015.
  • Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, et al.: Pomegranate juice, total pomegranate ellagitannins and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 54, 980–985, 2006.
  • Banerjee N, Kim H, Talcott S and Mertens-Talcott S: Pomegranate polyphenolics suppressed azoxymethane-induced colorectal aberrant crypt foci and inflammation: possible role of miR-126/VCAM-1 and miR-126/PI3K/AKT/mTOR. Carcinogenesis 34 (12), 2814–2822, 2013.
  • Malik M, Zhao C, Schoene N, Guisti MM, Moyer MP, et al.: Anthocyanin-rich extract from Aronia meloncarpa E induces a cell cycle block in colon cancer but not normal colonic cells. Nutr Cancer 46, 186–196, 2003.
  • Lee MS, Lee YK and Park OJ: Cherry silver berry (Elaeagnus multiflora) extracts exert antiinflammatory effects by inhibiting COX-2 and akt signals in HT-29 colon cancer cells. Food Sci Biotechnol 19, 1673–1677, 2010.
  • Kountouri AM, Gioxari A, Karvela E, Kaliora AC, Karvelas M, et al.: Chemopreventive properties of raisins originating from Greece in colon cancer cells. Food Funct 4, 366–372, 2013.
  • Bounaama A, Enayat S, Ceyhan MS, Moulahoum H, Djerdjouri B, et al.: Ethanolic extract of bark from Salix aegyptiaca Ameliorates 1,2-dimethylhydrazine-induced colon carcinogenesis in mice by reducing oxidative stress. Nutr Cancer 68 (3), 495–506, 2016.
  • Huang HL, Liu CT, Chou MC, Ko CH and Wang CK: Noni (Morinda citrifolia L.) fruit extracts improve colon microflora and exert anti-inflammatory activities in Caco-2 cells. J Med Food 18, 663–676, 2015.
  • Rodríguez-Ramiro I, Ramos S, López-Oliva E, Agís-Torres A, Bravo L, et al.: Cocoa polyphenols prevent inflammation in the colon of azoxymethane-treated rats and in TNF-α-stimulated Caco-2 cells. Br J Nutr 110, 206–215, 2013.
  • Corona G, Deiana M, Incani A, Vauzour D, Dessì MA, et al.: Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects. Biochem Biophys Res Commun 362, 606–611, 2007.
  • Kim J, Soh SY, Shin J, Cho CW, Choi YH, et al.: Bioactives in cactus (Opuntia ficus-indica) stems possess potent antioxidant and pro-apoptotic activities through COX-2 involvement. J Sci Food Agric 95, 2601–2606, 2014.
  • Rosenberg DW, Giardina C and Tanaka T: Mouse models for the study of colon carcinogenesis. Carcinogenesis 30, 183–196, 2009.
  • Raju J: Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer. World J Gastroenterol 14, 6632–6635, 2008.
  • Silva RM, Campanholo VM, Paiotti AP, Artigiani Neto R, Oshima CT, et al.: Chemopreventive activity of grape juice concentrate (G8000TM) on rat colon carcinogenesis induced by azoxymethane. Environ Toxicol Pharmacol 40, 870–875, 2015.
  • Derry MM, Raina K, Balaiya V, Jain AK, Shrotriya S, et al.: Grape seed extract efficacy against azoxymethane-induced colon tumorigenesis in A/J mice: interlinking miRNA with cytokine signaling and inflammation. Cancer Prev Res (Phila) 6, 625–633, 2013.
  • Miller KB, Stuart DA, Smith NL, Lee CY, McHale NL, et al.: Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J Agric Food Chem 54, 4062–4068, 2006.
  • Vinson JA, Proch J, Bose P, Muchler S, Taffera P, et al.: Chocolate is a powerful ex vivo and in vivo antioxidant, an antiatherosclerotic agent in an animal model and a significant contributor to antioxidants in the European and American Diets. J Agric Food Chem 54, 8071–8076, 2006.
  • Hong MY, Nulton E, Shelechi M, Hernández LM and Nemoseck T: Effects of dark chocolate on azoxymethane-induced colonic aberrant crypt foci. Nutr.Cancer 655, 677–685, 2013.
  • Lala G, Malik M, Zhao C, He J, Kwon Y, et al.: Anthocyanin-rich extracts inhibit multiple biomarkers of colon cancer in rats. Nutr Cancer 54, 84–93, 2006.
  • Lai CS, Li S, Liu CB, Miyauchi Y, Suzawa M, et al.: Effective suppression of azoxymethane-induced aberrant crypt foci formation in mice with citrus peel flavonoids. Mol Nutr Food Res 57, 551–555, 2013.
  • Shi N, Clinton SK, Liu Z, Wang Y, Riedl KM, et al.: Strawberry phytochemicals inhibit azoxymethane/dextran sodium sulfate-induced colorectal carcinogenesis in CRJ: CD-1 mice. Nutrients 7, 1696–715, 2015.
  • Metz N, Lobstein A, Schneider Y, Gossé F, Schleiffer R, et al.: Suppression of azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract. Nutr Cancer 38, 60–64, 2000.
  • Luceri C, Caderni G, Sanna A and Dolara P: Red wine and black tea polyphenols modulate the expression of cycloxygenase-2, inducible nitric oxide synthase and glutathione-related enzymes in azoxymethane-induced F344 rat colon tumors. J Nutr 132, 1376–1379, 2002.
  • Caderni G, De Filippo C, Luceri C, Salvadori M, et al.: Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 21, 1965–1969, 2000.
  • Nguyen AV, Martinez M, Stamos MJ, Moyer MP, et al.: Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res 1, 25–37, 2009.
  • Holcombe RF, Martinez M, Planutis K and Planutiene M: Effects of a grape-supplemented diet on proliferation and Wnt signaling in the colonic mucosa are greatest for those over age 50 and with high arginine consumption. Nutr J 14, 1–8, 2015.
  • Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, et al.: Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev 17, 3020–3025, 2008.
  • Rostom A, Dube C, Lewin G, Tsertsvadze A, et al.: Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146, 376–389, 2007.
  • Stingl JC, Ettrich T, Muche R, Wiedom M, et al.: Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population. BMC Cancer 11, 1–9, 2011.
  • Sharma RA, McLelland HR, Hill KA, Ireson CR, et al.: Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7, 1894–1900, 2001.
  • Thomasset S, Berry DP, Cai H, West K, et al.: Pilot study of oral anthocyanins for colorectal cancer chemoprevention. Cancer Prev Res (Phila) 2, 625–633, 2009.
  • Wang LS, Arnold M, Huang YW, Sardo C, et al.: Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study. Clin Cancer Res 17, 598–610, 2011.
  • Wang LS, Burke CA, Hasson H, Kuo CT, et al.: A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev Res 7, 666–674, 2014.
  • Nuñez-Sánchez MA, García-Villalba R, Monedero-Saiz T, García-Talavera NV, et al.: Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Mol Nutr Food Res 58, 1199–1211, 2014.
  • Citronberg J, Bostick R, Ahearn T, Turgeon DK, et al.: Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized and controlled trial. Cancer Prev Res 6, 271–281, 2013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.